Results 191 to 200 of about 25,148 (262)

The clinical utility of nasal MRSA PCR as an antimicrobial stewardship tool to guide MRSA bacteraemia therapy in paediatrics: a retrospective study at a tertiary care centre. [PDF]

open access: yesJAC Antimicrob Resist
Alrashed F   +12 more
europepmc   +1 more source

Gut Microbiota as a Key Modulator in the Pathophysiology of Sepsis: SURVEIL Project

open access: yesMicrobiologyOpen, Volume 15, Issue 3, June 2026.
Longitudinal profiling of 132 hospitalized patients reveals that age, colonization status, and sepsis interact to shape gut microbiota diversity and composition. Sepsis is associated with reduced alpha diversity, beta‐diversity shifts, functional predictions (methanogenesis, nitrate/sulfate respiration), and partial MDR overlap with bloodstream ...
Chiara Bazzano   +22 more
wiley   +1 more source

When First‐Line Therapies Fail: Surgical Site Infections and the Declining Antimicrobial Utility in a Resource‐Limited Nation

open access: yesMicrobiologyOpen, Volume 15, Issue 3, June 2026.
In Belize, a 7‐year nationwide study reveals a sharp rise in antimicrobial resistance in surgical infections. ESBL‐producing bacteria more than doubled to > 45%, with critical treatment gaps and geographic hotspots identified. Sentinel pan‐drug‐resistant cases and a correlation between antibiotic use and resistance underscore the urgent need for ...
Innocent E. Nwachukwu   +5 more
wiley   +1 more source

Biovigilance in Faecal Microbiota Transplantation: 7-Year Cohort Study and Framework for Microbiological Assessments of Infectious Adverse Events. [PDF]

open access: yesUnited European Gastroenterol J
Chernova VO   +10 more
europepmc   +1 more source

Host–Pathogen Dual Targeting With Repurposed Drugs Identifies a Synergistic Therapy for Intracellular Staphylococcus aureus

open access: yesMicrobiologyOpen, Volume 15, Issue 3, June 2026.
A large intracellular drug‐repurposing screen identifies a potent synergy between 5‐fluoro‐2′‐deoxycytidine and rifapentine, acting through dual host–pathogen targeting to reduce Staphylococcus aureus burdens across strains, cell types, and infection models (created with BioRender).
Blanca Lorente‐Torres   +13 more
wiley   +1 more source

Therapeutic strategies for multi-resistant <i>Escherichia coli</i> in urinary tract infections-a cause for concern. [PDF]

open access: yesJAC Antimicrob Resist
Unni R   +7 more
europepmc   +1 more source

Retiring rusty myths around intravenous iron

open access: yes
HemaSphere, Volume 10, Issue 6, June 2026.
Lauren E. Merz, Arielle L. Langer
wiley   +1 more source

Long-term trends in incidence and mortality in Staphylococcus aureus bacteraemia; a retrospective population-based study from Central Norway 1996-2022. [PDF]

open access: yesBMC Infect Dis
Haugan I   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy